Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Recurrent melanoma is the return of melanoma after initial treatment, either local (near original site), regional (lymph nodes), or distant (metastatic to organs). It occurs in 5-10% of stage I-II, 20-30% of stage III. In 2025, ~10,000 US cases, with risk highest in first 2-3 years post-treatment.
Symptoms include new skin lesions/moles near scar, swollen lymph nodes, lumps under skin, persistent cough (lung recurrence), abdominal pain (liver), bone pain, headaches/seizures (brain), or fatigue/weight loss. Early recurrence may be asymptomatic, detected via surveillance.
Recurrence results from residual microscopic cells evading initial therapy, driven by mutations (BRAF, NRAS) and immune escape. Risks include high initial stage, ulceration, high mitosis, and inadequate margins. In 2025, ctDNA predicts recurrence risk.
Diagnosis uses physical exam, imaging (CT, PET, MRI), biopsy, and blood tests (LDH). Surveillance includes skin checks and scans. In 2025, liquid biopsies detect recurrence early.
Local recurrence uses surgery/radiation; regional adds lymphadenectomy/immunotherapy; distant uses targeted (BRAF inhibitors), immunotherapy (ipilimumab + nivolumab), or ADCs. In 2025, TIL therapy achieves 40% response.
In 2025, 5-year survival post-recurrence is 30-50% for regional, 10-20% for distant. TIL and combinations improve to 40%. By 2030, vaccines/ctDNA could raise to 60%.
The information for recurrent melanoma is sourced from NCI’s “Melanoma Treatment” for overview; Mayo Clinic’s “Recurrent Melanoma – Symptoms and causes” for symptoms; PMC’s “Recurrent Melanoma: Current Trends” for updates; Healthline’s “Recurrent Melanoma: Symptoms, Causes, Diagnosis” for diagnosis; Cleveland Clinic’s “Recurrent Melanoma” for treatment.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan